development and well aware of the ESG impacts. Hence, in the second quarter of fiscal year 2023, the Company has initiated hire purchase loans for products that reducing environmental impact, such as electric
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
Ratio), as specified in the Terms of Rights, effective from the end of the fiscal year of 2023 until the end of the fiscal year of 2025, and for allowing the issuer to enter any negotiations or
investments and diversify their portfolios across various assets, and expand new investor base, enhance investment services in the stock market and securities company products, as well as create a wealth
Province.The Securities and Exchange Commission (SEC), represented by the Capital Market Education Department, collaborated with the Fiscal Policy Office (FPO), the Deposit Protection Agency (DPA), and the Bank
, on 30 July 2024, the SEC received the overall score of 90.08 from the NACC’s ITA for the fiscal year 2024, an improvement from the previous year’s assessment. The areas that received higher scores
Organization.The Securities and Exchange Commission (SEC), led by the Capital Market Education Department, collaborated with representatives from the Fiscal Policy Office (FPO), the Deposit Protection Agency (DPA
. Pornchai Thiraveja, Director General of the Fiscal Policy Office, (3) Mr. Ronadol Numnonda, Assistant Manager of the Bank of Thailand, (4) Mr. Pakorn Peetathawatchai, President of the Stock Exchange of